Search research articles
Contact Us
Filters
Showing results (51-60 of 217) with videos related to
Page
of 22
Sort By:
Neuro-Oncology
|
January 12, 2021
PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma
Shaofang Wu, Xiaolong Li, Feng Gao, et al.
Cancer Investigation
|
November 27, 2002
CI-980 for the treatment of recurrent or progressive malignant gliomas: national central nervous system consortium phase I-II evaluation of CI-980
Lara J Kunschner, Howard Fine, Kenneth Hess, et al.
Journal of Neuro-Oncology
|
March 26, 2013
Outcomes for patients with anaplastic astrocytoma treated with chemoradiation, radiation therapy alone or radiation therapy followed by chemotherapy: a retrospective review within the era of temozolomide
Nicole A Shonka, Brett Theeler, Daniel Cahill, et al.
Neuro-Oncology
|
October 11, 2017
Activation of WEE1 confers resistance to PI3K inhibition in glioblastoma
Shaofang Wu, Shuzhen Wang, Feng Gao, et al.
Journal of Neuro-Oncology
|
June 14, 2013
Bevacizumab use in disseminated choroid plexus papilloma
Mark Daniel Anderson, Brett J Theeler, Marta Penas-Prado, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
December 3, 2014
Supratentorial extraventricular anaplastic ependymoma with extracranial metastasis
Laura A Pachella, Carlos Kamiya-Matsuoka, Eva Lu T Lee, et al.
Plos One
|
October 3, 2012
Identification of common prognostic gene expression signatures with biological meanings from microarray gene expression datasets
Jun Yao, Qi Zhao, Ying Yuan, et al.
Molecular and Cellular Biology
|
July 1, 2005
Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation
Juinn-Lin Liu, Xiaoyang Sheng, Zsuzsanna K Hortobagyi, et al.
Cancer Research
|
November 16, 2014
Retraction: Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig 2-positive glioma tumor-initiating cells
Dimpy Koul, Jun Yao, Shuzhen Wan, et al.
International Journal of Oncology
|
January 14, 2004
Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas
Julie A Cerrato, Tahira Khan, Dimpy Koul, et al.
Page
of 22
Search research articles
Search
Showing results (51-60 of 217) with videos related to
Sort By:
Page
of 22
Neuro-Oncology
|
January 12, 2021
PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma
Shaofang Wu, Xiaolong Li, Feng Gao, et al.
Cancer Investigation
|
November 27, 2002
CI-980 for the treatment of recurrent or progressive malignant gliomas: national central nervous system consortium phase I-II evaluation of CI-980
Lara J Kunschner, Howard Fine, Kenneth Hess, et al.
Journal of Neuro-Oncology
|
March 26, 2013
Outcomes for patients with anaplastic astrocytoma treated with chemoradiation, radiation therapy alone or radiation therapy followed by chemotherapy: a retrospective review within the era of temozolomide
Nicole A Shonka, Brett Theeler, Daniel Cahill, et al.
Neuro-Oncology
|
October 11, 2017
Activation of WEE1 confers resistance to PI3K inhibition in glioblastoma
Shaofang Wu, Shuzhen Wang, Feng Gao, et al.
Journal of Neuro-Oncology
|
June 14, 2013
Bevacizumab use in disseminated choroid plexus papilloma
Mark Daniel Anderson, Brett J Theeler, Marta Penas-Prado, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
December 3, 2014
Supratentorial extraventricular anaplastic ependymoma with extracranial metastasis
Laura A Pachella, Carlos Kamiya-Matsuoka, Eva Lu T Lee, et al.
Plos One
|
October 3, 2012
Identification of common prognostic gene expression signatures with biological meanings from microarray gene expression datasets
Jun Yao, Qi Zhao, Ying Yuan, et al.
Molecular and Cellular Biology
|
July 1, 2005
Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation
Juinn-Lin Liu, Xiaoyang Sheng, Zsuzsanna K Hortobagyi, et al.
Cancer Research
|
November 16, 2014
Retraction: Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig 2-positive glioma tumor-initiating cells
Dimpy Koul, Jun Yao, Shuzhen Wan, et al.
International Journal of Oncology
|
January 14, 2004
Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas
Julie A Cerrato, Tahira Khan, Dimpy Koul, et al.
Page
of 22